drugset / Trial / NCT01185925

Exercise Oscillatory Breathing and Sildenafil in Heart Failure

NCT01185925

Phase 2 Completed 32 enrolled University of Milan
RandomizedParallel-groupTriple-blindTreatment

Summary

Exercise oscillatory breathing (EOB) is a ventilatory abnormality that occurs in approximately 20% of heart failure (HF) patients and carries a very unfavourable prognosis. Pathophysiology seems quite complex and putative mechanisms include increased pulmonary capillary pressure and pulmonary vasoconstriction, circulatory blood-flow fluctuations in the pulmonary arterial system and instability of ventilatory control. Inhibition of the phosphodiesterase 5 (PDE5) isoenzyme favourably regulates pulmonary vascular tone and permeability through over signaling of the endothelial nitric oxide pathway. The investigators tested the hypothesis that sildenafil would reverse the EOB pattern in patients with HF and pulmonary hypertension.

Timeline

Start
2008-04
Primary completion
2009-12
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg

Indications